-
Mike Jay to Chair Molecular Pharmaceutics
-
Mike Jay, PhD, succeeds Leaf Huang, PhD, as chair of the Division of Molecular Pharmaceutics. Jay is highly regarded in the fields of drug delivery and radiopharmaceutics.
Located in
News
/
Current News
-
UNC Research Center Receives Contract to Fight Kidney Cancer
-
William Janzen of the Center for Integrative Chemical Biology and Drug Discovery and Kimryn Rathmell of the UNC School of Medicine are leading research to develop potential drug leads for treating renal cell carcinoma.
Located in
News
/
Current News
-
Arthritis Researcher Blalock Promoted to Professor
-
Susan Blalock, MPH, PhD, is a behavioral scientist who has focused primarily on the prevention and treatment of arthritis during her career.
Located in
News
/
Current News
-
Rodgers Elected to National Academies of Practice
-
Jo Ellen Rodgers, PharmD, has been elected as an distinguished practitioner and fellow in the NAP Pharmacy Academy, an organization that advise public-policy makers on health-care issues.
Located in
News
/
Current News
-
Emekalam Receives Subgrant to Fight Diabetes
-
The funding will support a pilot program that recruits local ministers to help persuade members of the black community to follow individually tailored diabetes-management regimens.
Located in
News
/
Current News
-
Weeks Promoted to Elizabeth City Assistant Dean Post
-
The clinical assistant professor will work to maintain and expand the UNC/ECSU Doctor of Pharmacy Partnership Program and will support the needs of the students based on the ECSU campus.
Located in
News
/
Current News
-
Phil Rodgers Named Assistant Dean for Pharmacy Practice Partnerships
-
The UNC alum was a clinical pharmacist and faculty in ambulatory care at Duke University Hospital before joining the School's faculty.
Located in
News
/
Current News
-
Professor Tim Ives to Chair AACP Board of Sections
-
Professor Timothy Ives, PharmD, MPH, is the chair-elect for the AACP's Council of Sections and will officially assume his duties in July 2012.
Located in
News
/
Current News
-
UNC Study Could Lead to Treatment for Angelman Syndrome
-
The researchers have found a way to counter the gene mutation or deletion that causes the neurogenetic disease. Their findings have been published online in the journal Nature.
Located in
News
/
Current News
-
Associate Professor Wiltshire Receives Tenure
-
Pharmacogenomics researcher Tim Wiltshire, PhD, joined the School in 2007 and is the associate director of the UNC Institute for Pharmacogenomics and Individualized Therapy.
Located in
News
/
Current News
